Flash ReportClorox (CLX) 2Q16 Results: Mixed Quarter, Company Raises EPS Guidance Coresight Research February 4, 2016 Executive Summary Clorox reported fiscal 2Q16 revenues of $1.3 billion, flat year over year and slightly below the consensus estimate. Diluted EPS from continuing operations were $1.14, up 18% year over year and exceeding the consensus estimate of $1.05. Cleaning and Lifestyle products each posted a 2% volume gain. Clorox Disinfecting Wipes were up by double digits, and Natural Personal Care products posted double-digit volume growth for the second year in a row. The company raised its fiscal 2016 EPS guidance to $4.75–$90 from $4.68–$4.83 due to expectations of higher EBIT margins. Please Login to read the full report. Not a member? To access this content for free, register for a free account. This document was generated for Other research you may be interested in: US Drugstore and Pharmacy Retailing: Market Forecast and Competitive Landscape—The Pharmacy ShakeoutLower-Income Consumers’ Economic and Financial Sentiment Improves: US Consumer Survey InsightsShoptalk Fall 2025 Day Two: Scaling Pilots, Pivoting with Intelligence and Building Next-Gen Customer ExperiencesAnalyst Corner: The Shifting “Friction Gap” Between Stores and E-Commerce Is Benefitting Digital Channels, with John Mercer
